DPP-4 inhibitors are being developed for administration once weekly, too
Semaglutide: First-Generation GLP-1 Option Semaglutide is a GLP-1 receptor agonist
It also includes supportive structures around it: Ligaments that stabilize Tendons that connect muscle to bone Muscles that absorb force and control movement Special cartilage structures like the meniscus in the knee or the labrum in the hip When any part of that system breaks down, the joint can become painful, unstable, weak, or stiff
Cardiovascular effects: Some patients experience modest reductions in blood pressure whilst taking GLP-1 receptor agonists, which is generally beneficial for cardiovascular health but can occasionally cause postural hypotension or light-headedness, particularly in individuals already taking antihypertensive medications
These include lifestyle modification requirements (69%), trialing lower-cost medications first (63%) and limiting therapy duration (63%)